Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New registry to compare cryoablation and surgery for painful endometriosis

NCT ID NCT06356831

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a national registry to collect data on people with parietal endometriosis, a condition where endometriosis tissue grows in the abdominal wall. Researchers will track those treated with either surgery or a less invasive technique called cryoablation (freezing the nodules). The goal is to better understand the disease and compare treatment outcomes, not to test a new cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patient with endomecriosis at least 18 years of age who will be oer are treate by cryo ablation or surgical treatement

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Presence of parietal endometriosis: with suggestive clinical and imaging criteria (MRI and ultrasound) * Symptomatic parietal endometriosis (VAS \> 3 OR bothersome bleeding OR reported impact on quality of life) Exclusion Criteria: * Endometriosis not affecting the anterior wall of the abdomen (as deep pelvic muscle: ilio-psoas, obturators, perineal, ischio-anal fossa) * Minor patient (\< 18 years) * Pregnant patient at any trimester * Patient with hemostasis disorders (constitutional or acquired) * Patient with systemic infection or localized scar infection upon inclusion. * Patient with contraindications to MRI * Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study. * Patient unable to understand the information provided * Patient who is not affiliated to the social security system * Patient under curatorship or tutorship * Patient with a nodule of primary or secondary malignant tumor origin

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cryotherapy effect are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    15 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AP-HP - Tenon

    RECRUITING

    Paris, France

  • AP-HP Hôpital Européen Georges Pompidou

    RECRUITING

    Paris, France

  • APHM-Hôpital Nord

    ACTIVE_NOT_RECRUITING

    Marseille, France

  • APHP Cochin-Port Royal

    RECRUITING

    Paris, France

  • APHP-Hôpital la Conception La Timone

    RECRUITING

    Marseille, France

  • APHP-La Pitié

    RECRUITING

    Paris, France

  • CH Valencienne

    RECRUITING

    Valenciennes, France

  • CHI Creteil

    RECRUITING

    Créteil, France

  • CHU Clermont Ferrand

    RECRUITING

    Clermont-Ferrand, France

  • CHU Montpellier

    RECRUITING

    Montpellier, France

  • CHU Nime

    RECRUITING

    Nîmes, France

  • CHU Strasbourg

    ENROLLING_BY_INVITATION

    Strasbourg, France

  • CHU Toulouse

    ACTIVE_NOT_RECRUITING

    Toulouse, France

  • CHU bordeaux

    RECRUITING

    Bordeau, France

  • Clinique Tivoli

    RECRUITING

    Bordeaux, France

  • Lyon Hôpital La Croix Rousse

    RECRUITING

    Lyon, France

  • Lyon Hôpital Sud

    RECRUITING

    Lyon, France

  • Lyon Louis Pradel

    ACTIVE_NOT_RECRUITING

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.